| Authors: |
Lehman SE; National Institute of Standards and Technology, Gaithersburg, Maryland, USA., Vreeland WN; National Institute of Standards and Technology, Gaithersburg, Maryland, USA., Blaszczyk AJ; United States Pharmacopeia, Rockville, Maryland, USA., Adams-Hall S; Pfizer, New York, New York, USA., Ahuja S; Prevail Therapeutics, New York, New York, USA., Arnaout A; Prevail Therapeutics, New York, New York, USA., Balduf H; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA., Budyak IL; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA., Carbonell RG; NIIMBL (National Institute for Innovation in Manufacturing Biopharmaceuticals), Newark, Delaware, USA., Charlebois T; NIIMBL (National Institute for Innovation in Manufacturing Biopharmaceuticals), Newark, Delaware, USA., Cleveland TE 4th; National Institute of Standards and Technology, Gaithersburg, Maryland, USA., Deng JZ; Merck, Rahway, New Jersey, USA., Doyle BL; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA., Duewer DL; National Institute of Standards and Technology, Gaithersburg, Maryland, USA., Elger C; Roche Diagnostics GmbH, Penzberg, Germany., Fagan JA; National Institute of Standards and Technology, Gaithersburg, Maryland, USA., Guo T; United States Pharmacopeia, Rockville, Maryland, USA., Haller J; Prevail Therapeutics, New York, New York, USA., Hilgenfeld LD; Roche Diagnostics GmbH, Penzberg, Germany., Hoang VM; Spark Therapeutics, Philadelphia, Pennsylvania, USA., Huldin AJL; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA., Hyatt M; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA., Jacques J; United States Pharmacopeia, Rockville, Maryland, USA., Kar S; Spark Therapeutics, Philadelphia, Pennsylvania, USA., Kedia SB; NIIMBL (National Institute for Innovation in Manufacturing Biopharmaceuticals), Newark, Delaware, USA., Kokona B; Spark Therapeutics, Philadelphia, Pennsylvania, USA., Liu A; United States Pharmacopeia, Rockville, Maryland, USA., Ma L; United States Pharmacopeia, Rockville, Maryland, USA., McCarthy D; United States Pharmacopeia, Rockville, Maryland, USA., Noble E; Pfizer, New York, New York, USA., Oettl V; Roche Diagnostics GmbH, Penzberg, Germany., Pla A; Prevail Therapeutics, New York, New York, USA., Powers TW; Pfizer, New York, New York, USA., Richardson J; United States Pharmacopeia, Rockville, Maryland, USA., Ripple DC; National Institute of Standards and Technology, Gaithersburg, Maryland, USA., Runnels HA; Pfizer, New York, New York, USA., Ruppert R; Roche Diagnostics GmbH, Penzberg, Germany., Semmelmann F; Roche Diagnostics GmbH, Penzberg, Germany., Sims CM; National Institute of Standards and Technology, Gaithersburg, Maryland, USA., Singh S; Pfizer, New York, New York, USA., Vogt A; Spark Therapeutics, Philadelphia, Pennsylvania, USA., Wenzel S; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA., Whitaker N; Spark Therapeutics, Philadelphia, Pennsylvania, USA., Yang Z; United States Pharmacopeia, Rockville, Maryland, USA., Zhuang B; Prevail Therapeutics, New York, New York, USA. |